A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women

被引:0
|
作者
Andrea Lukes
Elizabeth Migoya
Brendan Johnson
Tien-Yi Lee
Yulan Li
Juan Camilo Arjona Ferreira
机构
[1] Carolina Women’s Research and Wellness Center,
[2] Myovant Sciences,undefined
[3] Inc.,undefined
[4] Roivant Sciences,undefined
[5] Inc.,undefined
来源
Clinical Pharmacokinetics | 2023年 / 62卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1169 / 1182
页数:13
相关论文
共 50 条
  • [31] Relugolix in combination with abiraterone acetate, apalutamide, or docetaxel in men with advanced prostate cancer (aPC): A phase 1, three-part, open-label, parallel-cohort study.
    De La Cerda, Jose
    Migoya, Elizabeth
    Brown, Bruce
    Lu, Sophia
    Zohren, Fabian
    Tutrone, Ronald F.
    Dunshee, Curtis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [32] RELUGOLIX COMBINATION THERAPY IN NORTH AMERICAN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: SPIRIT 1 AND 2 TRIALS
    As-Sanie, Sawsan
    Brown, Eric L.
    Imm, So Jung
    Lessey, Bruce A.
    Perry, Julie Stein
    Giudice, Linda C.
    FERTILITY AND STERILITY, 2022, 118 (04) : E223 - E223
  • [33] A plain language summary of the long-term relugolix combination therapy study for uterine fibroids
    Al-Hendy, Ayman
    Lukes, Andrea S.
    Venturella, Roberta
    Villarroel, Claudio
    McKain, Laura
    Li, Yulan
    Wagman, Rachel B.
    Stewart, Elizabeth A.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (08)
  • [34] Plain language review: the safety of relugolix combination therapy for advanced prostate cancer
    De La Cerda, Jose
    Thorley, Jared
    Sieber, Paul
    Cookson, Michael S.
    Flanders, Scott C.
    Gatoulis, Sergio C.
    Shore, Neal D.
    FUTURE ONCOLOGY, 2025, 21 (01) : 51 - 62
  • [35] LIBERTY RANDOMIZED WITHDRAWAL STUDY: 2-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS.
    Al-Hendy, Ayman
    Venturella, Roberta
    Ferreira, Juan Camilo Arjona
    Li, Yulan
    Wagman, Rachel B.
    Lukes, Andrea S.
    FERTILITY AND STERILITY, 2021, 116 (03) : E2 - E2
  • [36] Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study
    Kiely, PDW
    Johnson, DM
    RHEUMATOLOGY, 2002, 41 (06) : 631 - 637
  • [37] Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: A randomized, open-label, crossover study
    Zema, MJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) : 640 - 646
  • [38] Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study
    Bahk, WM
    Shin, YC
    Woo, JM
    Yoon, BH
    Lee, JS
    Jon, DI
    Chung, SK
    Choi, SK
    Paik, IH
    Pae, CU
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (01) : 115 - 121
  • [39] Bleeding Patterns in Women with Endometriosis-Associated Pain Treated with Relugolix Combination Therapy: SPIRIT Program.
    Lukes, Andrea S.
    As-Sanie, Sawsan
    Becker, Christian M.
    Abrao, Mauricio S.
    Mehedintu, Claudia
    Reznichenko, Galyna
    Giudice, Linda
    Wang, Furong
    Rakov, Viatcheslav G.
    Warsi, Qurratul A.
    REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 55A - 55A
  • [40] CHARACTERIZATION OF PITUITARY AND OVARIAN HORMONE CONCENTRATIONS DURING TREATMENT WITH RELUGOLIX COMBINATION THERAPY.
    Duijkers, Ingrid
    Migoya, Elizabeth M.
    Ferreira, Juan Camilo Arjona
    Klipping, Christine
    FERTILITY AND STERILITY, 2020, 114 (03) : E81 - E81